Ubigel Inperio restores and regenerates the oral mucosa offering a non-surgical solution for periodontitis therapy. Periodontitis It is a very widespread and disabling disease that impacts 19% in people over the age of 15, representing over 1 billion cases worldwide. Non-surgical therapy is considered the gold standard for the initial treatment of inflammatory periodontal disease. 

Ubigel Inperio contains two gels in one product with double action: one with a filling function of the periodontal pockets, favoring tissues repair and the other with fixative function, avoiding the spreading action of saliva.

Ubigel Inperio is the first periodontal gel based on spermidine which is a physiological component of the tissues of the human body Its deficiency causes inflammatory events, with the capacity to promote the trophic effect and regeneration of tissues.

Ubigel inperio is an innovative medical device (class IIA) within the periodontitis product segment and it enriches the Pierrel product line.